ENDS industry


Aspire is proud to announce we have received PMTA Acceptance letter from the FDA on March 18, 2021. We have reached a step closer to meeting FDA criteria for a full scientific review before moving onto the next step of the PMTA process. The documentation includes a broad and exhaustive investigation with scientific evidence of the quality and safety of our electronic nicotine-delivery systems (ENDS). This letter confirms that Aspire’s application has met the preliminary…